Research study for adults with relapsing-remitting MS

Advertisement:
UVa Health System, Department of Neurology seeks men and women age 18 to 50 years with relapsing-remitting Multiple Sclerosis for research study.
The purpose of the study is to determine whether vitamin D3 supplementation as an add-on to Copaxone therapy will affect the relapse rate of MS. Study involves taking Copaxone by injection, as well as one of 2 doses of vitamin D. There are blood draws, surveys, neurological evaluations, urine pregnancy testing (for females of child-bearing potential), and MRI of the brain. There are 11 visits over 26 months, adding up to 2 hours to regular clinical visits for 6 visits, a 2 hour injection training visit, and the other visits lasting approximately 45 minutes. Eligible participants have had at least 1 recent relapse of their MS.
? Participant’s insurance company will be billed for clinic visits, MRIs, labs (after the screening labs)
? Study medication—Copaxone and vitamin D—are provided free of charge, as are 4 clinic visits with the research coordinator, and the screening labs
? No compensation is provided for this study.
Contact Information:
For more information please contact:
• Margaret Keller RN
• 434-243-5457 or mfk8e@virginia.edu
• IRB-HSR # 16493
Principal Investigator: David E. Jones MD